Robust analysis of study samples is important to optimize therapeutic benefit and discover biomarkers. Advance your therapeutic candidates through genomic and proteomic analysis.
Analyze your preclinical and non-CLIA regulated clinical samples with our diverse biomarker assay service, including:
CrownBio’s available services work perfectly as either standalone or part of an end-to-end, well-integrated preclinical program:
Tell us about your needs